These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 7779140

  • 1. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
    Moser U, Gubitz C, Galvan M, Immel-Sehr A, Lambrecht G, Mutshcler E.
    Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic properties of compounds related to arecaidine propargyl ester.
    Tumiatti V, Wehrle J, Hildebrandt C, Moser U, Dannhardt G, Mutschler E, Lambrecht G.
    Arzneimittelforschung; 2000 Jan; 50(1):11-5. PubMed ID: 10683710
    [Abstract] [Full Text] [Related]

  • 3. Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?
    Eltze M, König H, Ullrich B, Grebe T.
    Eur J Pharmacol; 1997 Jul 30; 332(1):77-87. PubMed ID: 9298928
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationships of new analogues of arecaidine propargyl ester at muscarinic M1 and M2 receptor subtypes.
    Moser U, Lambrecht G, Wagner M, Wess J, Mutschler E.
    Br J Pharmacol; 1989 Feb 30; 96(2):319-24. PubMed ID: 2924082
    [Abstract] [Full Text] [Related]

  • 5. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML, Minarini A, Budriesi R, Cacciaguerra S, Chiarini A, Spampinato S, Tumiatti V, Melchiorre C.
    J Med Chem; 1998 Oct 08; 41(21):4150-60. PubMed ID: 9767650
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW.
    J Med Chem; 1998 Jun 04; 41(12):2047-55. PubMed ID: 9622546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS, Abuh YF, Liu Y, Periyasamy S, Ngur DO, Edgar MA, El-Assadi AA, Sbeih S, Dunbar PG, Roknich S, Rho T, Fang Z, Ojo B, Zhang H, Huzl JJ, Nagy PI.
    J Med Chem; 1997 Apr 11; 40(8):1230-46. PubMed ID: 9111297
    [Abstract] [Full Text] [Related]

  • 13. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug 11; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U, Fuder H, Moser U, Bümert HG, Mutschler E, Lambrecht G.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan 11; 349(1):1-10. PubMed ID: 8139696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May 11; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 18. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD, Murkitt KL, Ho M, Watson JM, Brown F, Hunter AJ, Middlemiss DN.
    Br J Pharmacol; 1999 Apr 11; 126(7):1620-4. PubMed ID: 10323594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P.
    J Pharmacol Exp Ther; 1999 Jan 11; 288(1):164-70. PubMed ID: 9862767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.